Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Ascendis Pharma A/S
  6. Consensus
    ASND   US04351P1012

ASCENDIS PHARMA A/S

(ASND)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Evolution of the average Target Price on ASCENDIS PHARMA A/S
Target Price consensus revisions : last 18 months
Recommendations (Chart) ASCENDIS PHARMA A/S
Analyst Recommendations on ASCENDIS PHARMA A/S
01/13Wedbush Raises Price Target for Ascendis Pharma A/S to $189 From $186 on EU Approval for P..
MT
01/13Wedbush Cuts Ascendis Pharma's PT to $186 From $191 on Skytrofa Contraindication for PWS, ..
MT
01/06Cowen Starts Ascendis Pharma at Market Perform With $136 Price Target
MT
2021Wells Fargo Starts Ascendis Pharma at Overweight With $176 Price Target
MT
2021SVB Leerink Adjusts Ascendis Pharma's Price Target to $190 from $182, Keeps Outperform Rat..
MT
2021Credit Suisse Lowers Ascendis Pharma's PT to $179 from $185, Updates Model with Q3 Actuals..
MT
2021ASCENDIS PHARMA A/S : BofA Securities Downgrades Ascendis Pharma to Neutral From Buy, Lifts Price Target to $169..
MT
More recommendations
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 13
Last Close Price 107,73 €
Average target price 165,96 €
Spread / Average Target 54,1%
High Price Target 189,93 €
Spread / Highest target 76,3%
Low Price Target 119,05 €
Spread / Lowest Target 10,5%
Consensus detail
Consensus revision (last 18 months)